China Universal Asset Management Co., Ltd. Harmony Biosciences Holdings, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 12,093 shares of HRMY stock, worth $355,896. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,093
Previous 10,931
10.63%
Holding current value
$355,896
Previous $436,000
4.59%
% of portfolio
0.04%
Previous 0.05%
Shares
15 transactions
Others Institutions Holding HRMY
# of Institutions
262Shares Held
47MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$195 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$172 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$139 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$67.1 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$46.5 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.74B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...